IP Library › Granted Patent US 7,202,073
Granted Patent B2
US 7,202,073 · App. 10/371,905 · Granted Apr 10, 2007

Human analogs of murine deubiquitinating proteases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,073
App. No.
10/371,905
Granted
Apr 10, 2007
Kind
B2
Abstract

The present invention is directed to human analogs of murine hematopoetic-specific, cytokine-inducible deubiquinating proteases (“DUBs”) clustered on chromosomes 4 and 8 and their respective regulatory regions. The nucleotides or proteins encoded thereby my be used in assays to identify inhibitors of human DUBs.

Claims (1)

1. An isolated polypeptide comprising the human deubiquitinating protease hDUB4.1b (SEQ ID NO: 6).

Assignments (3)
MERGER Recorded Jan 19, 2015
From: AVENTIS PHARMACEUTICALS INC.
To: AVENTISUB LLC
Reel/Frame 034781/0334 →
CERTIFICATE OF CONVERSION Recorded Dec 9, 2014
From: AVENTISUB INC.
To: AVENTISUB LLC
Reel/Frame 034566/0976 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2007
From: HAHN, CHANG; LIU, HONG
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 018947/0257 →